Philip F Copenhaver - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Philip F Copenhaver

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

Journal of Alzheimer'S Disease : JAD|February 19, 2016

STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β ToxicityNora E Gray, Jonathan A Zweig, Colleen Kawamoto, et al.

The Journal of Comparative Neurology|March 10, 2007

Eph receptor expression defines midline boundaries for ephrin-positive migratory neurons in the enteric nervous system of Manduca sextaThomas M Coate, Tracy L Swanson, Thomas M Proctor, et al.

Frontiers in Molecular Neuroscience|December 10, 2016

Amyloid Precursor Proteins Are Dynamically Trafficked and Processed during Neuronal DevelopmentJenna M Ramaker, Robert S Cargill, Tracy L Swanson, et al.

Frontiers in Molecular Neuroscience|September 29, 2025

Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathwaysHun-Joo Lee, Zoe Bostick, John Doherty, et al.

Neurobiology of Disease|October 9, 2022

The novel estrogen receptor modulator STX attenuates Amyloid-β neurotoxicity in the 5XFAD mouse model of Alzheimer's diseaseJoseph F Quinn, Martin J Kelly, Christopher J Harris, et al.

Biorxiv : the Preprint Server for Biology|September 2, 2025

Autosomal Allelic Inactivation: Variable Replication and Dosage SensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.

Elife|July 8, 2026

Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.

Disease Models & Mechanisms|May 21, 2011

A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drugPhilip F Copenhaver, Thimmappa S Anekonda, Derek Musashe, et al.

Biorxiv : the Preprint Server for Biology|July 3, 2026

Identifying Novel Estrogenic Mitochondrial Targets in Hypothalamic Proopiomelanocortin Neurons by ChemoproteomicsJian Qiu, Martha A Bosch, Mya Wolfe, et al.

Pageof 2

Search research articles

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

Journal of Alzheimer'S Disease : JAD|February 19, 2016

STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β ToxicityNora E Gray, Jonathan A Zweig, Colleen Kawamoto, et al.

The Journal of Comparative Neurology|March 10, 2007

Eph receptor expression defines midline boundaries for ephrin-positive migratory neurons in the enteric nervous system of Manduca sextaThomas M Coate, Tracy L Swanson, Thomas M Proctor, et al.

Frontiers in Molecular Neuroscience|December 10, 2016

Amyloid Precursor Proteins Are Dynamically Trafficked and Processed during Neuronal DevelopmentJenna M Ramaker, Robert S Cargill, Tracy L Swanson, et al.

Frontiers in Molecular Neuroscience|September 29, 2025

Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathwaysHun-Joo Lee, Zoe Bostick, John Doherty, et al.

Neurobiology of Disease|October 9, 2022

The novel estrogen receptor modulator STX attenuates Amyloid-β neurotoxicity in the 5XFAD mouse model of Alzheimer's diseaseJoseph F Quinn, Martin J Kelly, Christopher J Harris, et al.

Biorxiv : the Preprint Server for Biology|September 2, 2025

Autosomal Allelic Inactivation: Variable Replication and Dosage SensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.

Elife|July 8, 2026

Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.

Disease Models & Mechanisms|May 21, 2011

A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drugPhilip F Copenhaver, Thimmappa S Anekonda, Derek Musashe, et al.

Biorxiv : the Preprint Server for Biology|July 3, 2026

Identifying Novel Estrogenic Mitochondrial Targets in Hypothalamic Proopiomelanocortin Neurons by ChemoproteomicsJian Qiu, Martha A Bosch, Mya Wolfe, et al.

Pageof 2